Target type: biologicalprocess
Any process that activates or increases the frequency, rate or extent of T-helper 17 cell differentiation. [GOC:BHF, GOC:mah]
Positive regulation of T-helper 17 cell differentiation is a complex and tightly regulated process that involves a cascade of signaling events, transcription factor activation, and cytokine production. It is essential for the development of a robust immune response against extracellular pathogens, such as fungi and bacteria. Here's a detailed breakdown of the process:
1. **Signal Initiation:** The process begins with the activation of naive T cells by antigen-presenting cells (APCs), such as dendritic cells. APCs present antigens in the context of MHC class II molecules, which are recognized by the T cell receptor (TCR) on the surface of naive T cells. This interaction, along with co-stimulatory signals from APCs, leads to the activation of the naive T cell.
2. **Cytokine Environment:** The differentiation of naive T cells into Th17 cells is heavily influenced by the cytokine environment. Interleukin-6 (IL-6) and transforming growth factor-beta (TGF-β) are crucial cytokines that initiate the Th17 cell differentiation program. IL-6 activates the STAT3 transcription factor, while TGF-β activates SMAD2/3 transcription factors.
3. **Transcription Factor Activation:** STAT3 and SMAD2/3, activated by IL-6 and TGF-β respectively, interact and form a complex that promotes the expression of RORγt, a master regulator of Th17 cell differentiation. RORγt directly activates the transcription of genes encoding key Th17 cytokines, including IL-17A, IL-17F, and IL-22.
4. **IL-17 Production and Function:** IL-17A and IL-17F, the signature cytokines of Th17 cells, play a crucial role in the immune response. IL-17A and IL-17F activate various cell types, including epithelial cells, fibroblasts, and immune cells. They induce the production of pro-inflammatory chemokines and cytokines, like IL-6, TNF-α, and CXCL8, leading to neutrophil recruitment and activation at sites of infection. These responses help to clear extracellular pathogens.
5. **Regulation and Feedback Mechanisms:** Positive regulation of Th17 cell differentiation is carefully regulated to prevent excessive inflammation and autoimmune diseases. Several feedback mechanisms are involved:
* **IL-2:** IL-2, produced by other T cells, inhibits Th17 differentiation and promotes the development of other T cell subsets, like regulatory T cells (Tregs).
* **IL-10:** IL-10, a potent anti-inflammatory cytokine, suppresses Th17 cell differentiation and function.
* **IL-23:** IL-23, produced by APCs, amplifies and stabilizes the Th17 cell phenotype.
6. **Th17 Cell Plasticity:** Th17 cells are not static and can exhibit plasticity, meaning they can switch their phenotype depending on the surrounding environment. They can transition to other T cell subsets, including Tregs and Th1 cells, under specific conditions.
In summary, the positive regulation of T-helper 17 cell differentiation is a highly regulated process involving cytokine signaling, transcription factor activation, and specific cytokine production. It plays a crucial role in immunity against extracellular pathogens while requiring tight regulation to avoid excessive inflammation and autoimmune diseases.'
"
Protein | Definition | Taxonomy |
---|---|---|
Mucosa-associated lymphoid tissue lymphoma translocation protein 1 | A mucosa-associated lymphoid tissue lymphoma translocation protein 1 that is encoded in the genome of human. [PRO:DNx, UniProtKB:Q9UDY8] | Homo sapiens (human) |
Compound | Definition | Classes | Roles |
---|---|---|---|
beta-lapachone | beta-lapachone : A benzochromenone that is 3,4-dihydro-2H-benzo[h]chromene-5,6-dione substituted by geminal methyl groups at position 2. Isolated from Tabebuia avellanedae, it exhibits antineoplastic and anti-inflammatory activities. beta-lapachone: antineoplastic inhibitor of reverse transcriptase, DNA topoisomerase, and DNA polymerase | benzochromenone; orthoquinones | anti-inflammatory agent; antineoplastic agent; plant metabolite |
thioridazine | thioridazine : A phenothiazine derivative having a methylsulfanyl subsitituent at the 2-position and a (1-methylpiperidin-2-yl)ethyl] group at the N-10 position. Thioridazine: A phenothiazine antipsychotic used in the management of PHYCOSES, including SCHIZOPHRENIA. | phenothiazines; piperidines | alpha-adrenergic antagonist; dopaminergic antagonist; EC 1.8.1.12 (trypanothione-disulfide reductase) inhibitor; EC 3.4.21.26 (prolyl oligopeptidase) inhibitor; first generation antipsychotic; H1-receptor antagonist; serotonergic antagonist |
mepazine | mepazine: major descriptor (66-85); on-line search PHENOTHIAZINES (66-85); Index Medicus search MEPAZINE (66-85); RN given refers to parent cpd pacatal : A phenothiazine derivative in which 10H-phenothiazine has an N-methylpiperidin-4-ylmethyl substituent at the N-10 position. | phenothiazines |